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ITMembrane polarity: A target for myocardial protection and reduced
inflammation in adult and pediatric cardiothoracic surgeryGeoffrey P. Dobson, PhDThe spectrum of opinion regarding the safety, simplic-
ity, clinical application and reversibility of cardiople-
gia varies from total scepticism and discouragement of
its use to advocacy of constant employment with re-
markable success. Similar disagreement exists as to
which of the cardioplegic agent is the best.
—Kaplan and Fisher1 (1959) p. 833
Kaplan and Fisher1 wrote these edifying words more than
50 years ago, after which there was a 15-year surgeon-
instigated moratorium on potassium cardioplegia. Today,
more than 2 metric tons of depolarizing potassium are
passed through the coronary arteries of 350,000 patients un-
dergoing elective coronary artery bypass graft (CABG) and
valvular operations each year in the United States and more
than 4 metric tons in more than 800,000 patients in the 2500
cardiac centers worldwide. Despite surgical proficiency and
medical innovation driving low in-hospital mortality rates of
1% to 3% for CABG surgery and approximately 6% for
valvular surgery,2 there remains an ongoing challenge to re-
duce postoperative complications, particularly in older pa-
tients with multiple comorbidities and in emergency and
redo procedures. Currently, about 10% of patients will
have postoperative low cardiac output syndrome,3 25% to
40% of CABG patients will have postoperative atrial
fibrillation, 4% to 40% may have some form of renal
dysfunction, 10% to 40%may have transient cognitive dys-
function and delirium, and of the total number of patients
undergoing cardiac surgery at tertiary referral centers 4%
to 11% may require prolonged intensive care, which carry
significantly higher mortality rates.3,4
The etiology of postoperative complications in adult car-
diac surgery or pediatric congenital corrective operations is
multifactorial and includes age, gender and ethnicity, cardio-
pulmonary bypass time, technical difficulty and urgency of
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The Journal of Thoracic and Carventricular ejection fraction, and pre-existing medical condi-
tions such as diabetes, obesity, renal disease, hypertension,
and metabolic disorders.3 High potassium concentrations in
cardioplegic solutions may be another contributing factor
for postoperative cardiac dysfunction and related
morbidity.5-7 During cardiac surgery, switching the heart’s
normal extracellular ‘‘milieu’’ from a warm, normokalemic,
aerobic environment where the membrane potential of
cardiac cells is in a polarized state, to a more hostile, cold,
ischemic environment where the cardiac cells are
depolarized, and then returning to its normal polarized state,
predisposes the myocardium and vascular endothelium to
injury.6,8-10 Currently, more than 99% of cardioplegic
solutions and most organ preservation solutions contain Kþ
concentrations of more than 15 mmol/L, which depolarize
the myocardial cell membrane potential from its natural
polarizing ‘‘set point’’ of around 80 mV to about 50
mV.5,6,8 This editorial will focus on the possible role of
hyperkalemia in postcardioplegia injury and the ongoing
search for new alternatives targeting membrane polarity.FIVE AREAS OF CONCERN WITH
DEPOLARIZING POTASSIUM CARDIOPLEGIA
From a scientific standpoint, there are at least 5 areas
of concern with potassium concentrations of 10 mmol/L
and above in surgical cardioplegic and heart preservation
solutions:
1. Cell membranes of the atria, Purkinje fibers, and ven-
tricles behave like what Leonard S. Gettes termed ‘‘a
potassium electrode,’’ meaning that during diastole
the membrane potential is close to a Nernstian potas-
sium potential over a range of extracellular Kþconcen-
trations.10 As extracellular Kþ concentration is
increased to 16 mmol/L (50 mV), the Naþ fast chan-
nel availability and Naþ conductance are dramatically
reduced and the heart arrests in diastole. Potassium-
induced depolarized arrest is associated with ionic
and metabolic imbalances, where Naþ and Ca2þ load-
ing can lead to myocardial dysfunction and microvas-
cular injury.10,11
2. High potassium concentration is a potent coronary va-
soconstrictor and prospasmotic agent, which can lead
to increased vascular resistance and impair delivery
and intramyocardial distribution of cardioplegic solu-
tion.8,10,12 Although moderate hypothermia may
partially offset the constrictive effects, coronarydiovascular Surgery c Volume 140, Number 6 1213
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highly vulnerable period of rewarming and arousal.13
3. High potassium concentration can depolarize and
activate the vascular endothelium to become leaky,
proinflammatory, and prothrombotic.13-16
4. High potassium concentration is associated with re-
perfusion arrhythmias and conduction disturbances.5,6
5. High potassium concentration has been associated
with postoperative low cardiac output and contractile
stunning.5,17
Parenthetically, caution should be exercised in singling
out high potassium concentration as the primary cause of in-
adequate surgical myocardial protection because injury has
a highly heterogeneous, multifactorial etiology. However,
accumulating evidence has exposed potentially deleterious
effects of potassium in the experimental setting. For many
decades, high concentrations of potassium have been used
as an investigative tool to maximally contract vascular aortic
and coronary rings and, more recently, as shown by Sohn
and colleagues,16 to activate human endothelial cells to pro-
duce superoxide (O2
) anions, an effect that was subse-
quently inhibited by a hyperpolarizing adenosine
triphosphate–sensitive potassium channel opener (HOE
234). In 2005, Matsuzaki and associates18 further reported
membrane depolarization–induced reactive oxygen species
generation when rat and mouse endothelial cells were
switched from a normokalemic (5.9 mmol/L Kþ) to a hyper-
kalemic bathing solution (24 mmol/L Kþ). Apart from elec-
tromechanical arrest and lowering oxygen demands, the
accumulating evidence suggests that depolarizing hyperka-
lemic cardioplegia offers little or no direct cardioprotection
to the adult or pediatric heart.A SEARCH FOR ALTERNATIVES TO HIGH
POTASSIUM CARDIOPLEGIA
Early concerns over high potassium concentrations date
back to the mid-to-late 1950s after controversy developed
over the ‘‘Melrose technique,’’ in which there were severe
postoperative complications.1 Since that time, there has
been a sporadic search for nondepolarizing alternatives, in-
cluding acetylcholine, low Naþ, highMg2þ, low Ca2þ, tetrodo-
toxin, beta-blockers (rapid and slow acting), calcium channel
blockers, adenosine and adenosine-enhancing agents, adeno-
sine triphosphate–sensitive potassium channel openers, and
local anesthetics.5,6,8,10 Unfortunately, none of the
alternatives has reached clinical adoption, and many have
surrendered their potential status as a primary arresting
agent to become servants to depolarizing potassium as
adjuncts. Today, the aftermath of tireless effort from
surgeons and scientists to minimize the inadequacies of
hyperkalemic cardioplegia is a vast array of strategies
involving different grades of hypothermia, platform
formulations (all-blood, hemodiluted, crystalloid),1214 The Journal of Thoracic and Cardiovascular Sura multitude of delivery modalities, and a pharmacopeia of
putative cardioprotective agents. There may be thousands of
‘‘home-spun’’ formulations and methodologies used by the
8000 or more practicing cardiac surgeons worldwide, with
continuing debate over which provides better protection.19
A recent survey of cardioplegic practice in the United King-
dom reported that 56% of surgeons performing on-pump
CABG surgery use cold blood, 14% use warm blood, 14%
use crystalloid, 21% use retrograde infusion, and 16% of
surgeons did not use any cardioplegia, but preferred cross-
clamp fibrillation.20Diversemyocardial protection strategies
also exist in heart transplantation, where the potassium con-
centration in crystalloid solutions varies by more than an or-
der of magnitude from 10 to 125 mmol/L Kþ, with a wide
variety of ionic compositions (eg, low sodium, low calcium,
low pH, impermeants), and there is much debate over which
is more cardioprotective.
The ongoing controversy over what constitutes the opti-
mal surgical cardioplegic solution in adults profoundly
affects pediatric and neonatal surgery, inasmuch as most pe-
diatric myocardial protection strategies have been derived
from the adult experience.7 Immature hearts differ structur-
ally, functionally, and metabolically from the adult heart,
and solutions developed for adult hearts may not be optimal
for the pediatric heart. In 2003, Malhotra and colleagues21
reported that cold St Thomas’ Hospital No. 2 solution pro-
vided no more protection for neonatal lamb hearts than 30
minutes of normothermic fibrillation; both groups showed
a 30% loss of end-systolic elastance. That 30 minutes of
cold, depolarizing, hyperkalemic cardioplegia is as effective
as warm fibrillatory arrest is surprising. The pediatric pheno-
type is crying out for help and current depolarizing cardio-
plegia strategies do not appear to provide optimal
protection.7
THEORETICAL ADVANTAGES OF KEEPING THE
CELL MEMBRANE IN A POLARIZED STATE
Although past attempts to develop a nondepolarizing
cardioplegic solution have not translated into use in human
cardiac surgery, the concept of keeping the cell membrane
at its normal polarized state has considerable scientific
merit. In the natural, normokalemic, polarized state there
are fewer membrane channels, pores, and exchangers
open compared with the depolarized state.6,8 When
the membrane is at or near its resting voltage of
around 80 mV, there are fewer ionic, metabolic, and
electrical imbalances, less coronary vasoconstriction, and
less Ca2þ loading.5,11 In contrast, depolarized cells
activate many voltage-dependent membrane channels
(Naþ window current, Ca2þ channels), pores, and ex-
changers (Naþ/Hþ and Naþ/Ca2þ),22 which can lead to Naþ
and Ca2þ loading, vasoconstriction, endothelial injury, ar-
rhythmias, and contractile stunning. In 2004, Dobson and
Jones8 proposed a new concept of polarized arrest andgery c December 2010
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FIGURE 1. A, Comparison of coronary vascular resistance (CVR) at 1
hour or 2 hours of arrest with adenosine–lidocaine (AL) containing 5.9,
10, or 16 mmol/L potassium. For 1-hour arrest groups, CVR ¼ 0.012
[Kþ, mmol/L]þ 0.200, R2 ¼ 0.78, and for 2-hour arrest groups, CVR ¼
0.025 [Kþ]þ0.183, R2 ¼ 0.94. The cell membrane potentials for different
groups were estimated on arrested hearts using the Nernstian distribution
;
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lidocaine (AL) in a normokalemic solution. Its proof-of-
concept has subsequently been demonstrated in the canine
model of cardiopulmonary bypass.23 Subsequent studies in
the isolated rat heart model relevant to heart transplantation
showed that the normokalemic AL polarizing concept de-
livered and maintained at cold or warmer temperatures
for arrest and reanimation conferred superior efficacy in
postreanimation contractile performance compared with
some popular hyperkalemic formulations.9,24
More recently, Sloots and Dobson10 examined the effect
of varying levels of extracellular potassium in AL cardiople-
gia (0.1, 3.0, 5.9, 10, and 16 mmol/L Kþ) on the transmem-
brane potential, coronary vascular resistance (CVR),
incidence of arrhythmias, time to first beat, and cardiac out-
put in the working rat heart after 1 hour and 2 hours of arrest
at 32C to 33C, thus isolating the effects of potassium con-
centrations on these variables. Hearts arrested with 0.1- and
3-mmol/L Kþ levels (hypokalemic cardioplegia) and the
higher 10- and 16-mmol/L Kþ concentrations (depolarizing
cardioplegia) had significantly higher CVRs during arrest
(Figure 1, A), a greater number of arrhythmias after reanima-
tion, and were ‘‘slow to recover’’ functionally (Figure 1, B),
with significantly lower cardiac output, stroke volume
(Figure 1, C), and contractility compared with normokale-
mic AL (5.9 mmol/L Kþ).10 Nearly 40% of hearts arrested
with AL (0.1 mmol/L Kþ) and 25 mmol/L Kþ alone failed
to recover heart rate, developed pressures, or cardiac output
after 1 hour of arrest at 32C to 33C. Sloots and Dobson10
concluded that AL normokalemic crystalloid solution arrests
and protects the myocardium and coronary vasculature with-
out the untoward effects of depolarizing hyperkalemia (10
mmol/L Kþ or above).of potassium, and these potentials agreed well with published potassium
electrode measurements. B, Relationship between the time to first beat
(TFB) at reanimation after 1 or 2 hours of arrest and the concentration of po-
tassium in AL cardioplegia solution (5.9, 10, and 16 mmol/L Kþ). After 1
hour, TFB (min) ¼ 0.313 [Kþ]þ0.570, R2 ¼ 0.99, and after 2 hours, TFB
(min)¼ 0.947 [Kþ]3.308, R2¼ 0.99. The membrane potentials were added
to the figure to show the different voltages of the 3 groups during arrest.
*P< .05 between AL 16 mmol/L 1 hour and 2 hours (2-tailed Student t
test). C, Relationship between stroke volume and increasing concentrations
of potassium in AL cardioplegic solution (5.9, 10, and 16 mmol/L Kþ) at 60
minutes of reperfusion for 1-hour and 2-hour arrest groups. After 1 hour of
arrest, stroke volume¼ 0.002 [Kþ, mmol/L]þ0.226, R2 ¼ 0.65, and after 2
hours, stroke volume ¼ 0.012 [Kþ]þ0.294, R2 ¼ 0.99. The membrane po-
tentials added to the figure show the different voltages of the 3 groups during
arrest. **P< .05 between AL 16 mmol/L 1 hour and 2 hours (2-tailed Stu-
dent t test). (Parts A, B, and C were modified from Sloots K, Dobson GP.
Normokalemic Adenosine–Lidocaine Cardioplegia: Importance of Main-
taining a Polarized Myocardium for Optimal Arrest and Reanimation.
J Thorac Cardiovasc Surg. 2010;139:1576-86.10)
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INFLAMMATION: A POSSIBLE LINK
Membrane polarity may also play a role in reducing the
inflammatory response and associated coagulation disorders
arising from surgical trauma and the impact of cardiopulmo-
nary bypass (see Figure 2). In 2006, Ward and colleagues25
reported that emigrated neutrophils, after adhering to
ventricular myocytes, caused an immediate membrane
depolarization, which contributed to an inflammatory-
linked generation of arrhythmias, cell injury, and contractile
dysfunction. Ward and colleagues25 further showed that
holding the membrane potential around the natural ‘‘rest-
ing’’ nondepolarized state reduced cell damage from inflam-
matory attack. They concluded: ‘‘Thus maneuvers that
precluded activation of the Naþchannels, for example, hold-
ing the resting membrane potential at80 mV, significantly
increased time to cell death or prevented contracture en-
tirely.’’25 Recently, Shi and colleagues26 reported that the
polarizing concept of normokalemic AL cardioplegia may
help to reduce the inflammatory response; they showed
that AL had a greater effect to reduce porcine neutrophil
priming and activation than did adenosine and lidocaine
alone, as indicated through a greater suppression of superox-
ide (O2
) anion generation. Thus the AL concept, in addition
to having possible indirect anti-inflammatory effects from
defending the resting membrane potential, has a drug
composition that directly inhibits neutrophil-mediated
inflammation. Future studies will determine whether theHigh Potassium Card
Global Ischemia
Vasoconstriction
      (spasm)
Ca  loading Endothelium
  Activation
Pro-inflammatoPro-oxidant
KK
Membrane Depo
Surgical Tra
Cardiopulmonary
FIGURE 2. Broad schematic of the effects of high potassium in cardioplegic
adverse effects on cardioprotection during adult and pediatric cardiac surgery.
1216 The Journal of Thoracic and Cardiovascular Suranti-inflammatory effects of AL exert protection on the heart
and other organs, including brain, lung, liver, kidney, and
the gastrointestinal tract. Targeting cell polarity to reduce
inflammation may also be clinically relevant for off-pump
cardiac surgery and other trauma states, including cardiac ar-
rest and hemorrhagic shock, with possible multiorgan bene-
fits.
Clinically, the normokalemic AL-polarizing concept of
arrest and protection is currently being used in a number
of US centers as Adenocaine (Hibernation Therapeutics,
Macon, Ga) all-blood microplegia. However, there is only
1 published case report using all-blood AL microplegia in
a high-risk adult patient undergoing cardiac surgery.27 In
addition, there is a 134-patient pediatric safety trial that
showed that AL crystalloid ‘‘one shot’’ with moderate hy-
perkalemia (10 mmol/L) appeared to be more protective
than AL with 20 mmol/L Kþ or 20 mmol/L Kþ alone.28
These 2 publications demonstrate safety and feasibility of
using AL cardioplegia in admittedly very small patient pop-
ulations. Despite these promising indications, no random-
ized, controlled clinical trials have been conducted
comparing the concept of polarized surgical arrest and rean-
imation using AL cardioplegia to traditional depolarizing
cardioplegia methods. These trials are essential before any
definitive statements can be made regarding the concept
of polarized arrest.
In conclusion, cardiac surgeons are currently facing
unprecedented challenges and pressures from surgeonioplegia
Regional Ischemia
Arrhythmias Stunning
ry Pro-coagulant
?
K
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uma
 Bypass
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Lshortages, health care providers, and an older patient popu-
lation with a higher risk comorbidity profile. In addition,
patients with failed angioplasties and other emergency situ-
ations, including those with heart failure, and complex
pediatric congenital corrective operations pose a serious
challenge to myocardial protection. Further innovation is
required from basic and clinical science, which may include
modifying the current hyperkalemic cardioplegic methods
with improved supportive therapies or developing new
nondepolarizing strategies with the overall goal toward
evidence-based adoption, standardization, and best practice.
The future of adult and pediatric cardiac surgery will be
invented, not predicted, as cardiology boldly attempted a de-
cade or so ago, and new myocardial protection strategies
and technologies may help to steer and reshape the surgical
landscape.
I thank Professor Jakob Vinten-Johansen for his continued
support over many years and Donna Rudd and Hayley Letson for
their valuable comments on the manuscript.References
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